OncoTherapy Science, Inc.

TSE:4564 Stock Report

Market Cap: JP¥6.2b

OncoTherapy Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4564?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,487,7590.548%
Individual Insiders29,423,40010.8%
General Public240,732,49088.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.8%.

Top Shareholders

Top 21 shareholders own 16.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.61%
Yusuke Nakamura
12,511,000JP¥287.8m0%no data
2.15%
Shuichi Nakatsuru
5,850,000JP¥134.6m0%no data
1.14%
Central Tanshi Co., Ltd., Asset Management Arm
3,099,600JP¥71.3m0%0.21%
1.08%
Yoichi Furukawa
2,943,000JP¥67.7m-25.4%no data
0.92%
Hirofumi Arakawa
2,487,400JP¥57.2m0%no data
0.86%
Rakuten Investment Management, Inc.
2,339,500JP¥53.8m52.2%0.02%
0.82%
Japan Securities Finance Co. Ltd., Asset Management Arm
2,225,100JP¥51.2m0%0.01%
0.74%
Long Corridor Asset Management Limited
2,000,000JP¥46.0m-75.6%0.31%
0.66%
SBI Okasan Asset Management Co., Ltd.
1,781,600JP¥41.0m0%0.01%
0.58%
Matsui Securities Co. Ltd., Asset Management Arm
1,570,300JP¥36.1m0%0.16%
0.42%
Simplex Asset Management Co., Ltd.
1,136,100JP¥26.1m0%0.02%
0.41%
SBI Holdings Inc., Asset Management Arm
1,114,211JP¥25.6m0%0.01%
0.41%
Shinichi Asai
1,111,100JP¥25.6m0%no data
0.37%
Katsumi Suzuki
1,000,000JP¥23.0m0%no data
0.36%
Kazuko Kitamura
978,000JP¥22.5m0%no data
0.31%
Hiroshi Takeuchi
850,000JP¥19.6m0%no data
0.3%
Takashi Maruta
828,000JP¥19.0m0%no data
0.29%
Koji Toyooka
783,900JP¥18.0m0%no data
0.018%
Yuka Yamane
50,000JP¥1.2m0%no data
0.011%
Miyako Takagi
31,000JP¥712.9k0%no data
0.00029%
Daiwa Asset Management Co., Ltd.
800JP¥18.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 21:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OncoTherapy Science, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.
Toshiyuki IwataMizuho Securities Co., Ltd.